Orale former for Ribavirin- monoterapi er blevet undersøgt til behandling af kronisk hepatitis C i flere kliniske undersøgelser.
Oral formulations of Ribavirin monotherapy have been investigated as therapy for chronic hepatitis C in several clinical trials.